BRPI0519330A2 - Ácido nuclÉico isolado; vetor; cÉlula hospedeira; mÉtodo para expressar uma proteÍna; polipeptÍdeo isolado; cromoproteÍna isolada; oligonucleotÍdeo; mÉtodo para identificar um Ácido nuclÉico que codifica uma apoproteÍna de um enediina de nove membros contendo cromoproteÍna; cultura biologicamente pura de actinomadura sp. 21g792 (nrrl 30778); mÉtodo para preparar uma cromoproteÍna; mÉtodo para preparar uma cromoproteÍna modificada; mÉtodo para inibir a progressço de uma doenÇa neoplÁsica em um mamÍfero; composiÇço farmacÊutica; e composto - Google Patents

Ácido nuclÉico isolado; vetor; cÉlula hospedeira; mÉtodo para expressar uma proteÍna; polipeptÍdeo isolado; cromoproteÍna isolada; oligonucleotÍdeo; mÉtodo para identificar um Ácido nuclÉico que codifica uma apoproteÍna de um enediina de nove membros contendo cromoproteÍna; cultura biologicamente pura de actinomadura sp. 21g792 (nrrl 30778); mÉtodo para preparar uma cromoproteÍna; mÉtodo para preparar uma cromoproteÍna modificada; mÉtodo para inibir a progressço de uma doenÇa neoplÁsica em um mamÍfero; composiÇço farmacÊutica; e composto

Info

Publication number
BRPI0519330A2
BRPI0519330A2 BRPI0519330-3A BRPI0519330A BRPI0519330A2 BR PI0519330 A2 BRPI0519330 A2 BR PI0519330A2 BR PI0519330 A BRPI0519330 A BR PI0519330A BR PI0519330 A2 BRPI0519330 A2 BR PI0519330A2
Authority
BR
Brazil
Prior art keywords
chromoprotein
isolated
nucleic acid
preparing
actinomadura
Prior art date
Application number
BRPI0519330-3A
Other languages
English (en)
Inventor
Bradley Haltli
Haiyin He
Ying Huang
Sridhar Krishna Rabindran
Jiang Wu
Min He
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0519330A2 publication Critical patent/BRPI0519330A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

ACIDO NUCLÉICO ISOLADO; VETOR; CÉLULA HOSPEDEIRA; MÉTODO PARA EXPRESSAR UMA PROTEÍNA; POLIPEPTÍDEO ISOLADO; CROMOPROTEÍNA ISOLADA; OLIGONUCLEOTÍDEO; MÉTODO PARA IDENTIFICAR UM ÁCIDO NUCLÉICO QUE CODIFICA UMA APOPROTEÍNA DE UM ENEDIINA DE NOVE MEMBROS CONTENDO CROMOPROTEÍNA; CULTURA BIOLOGICAMENTE PURA DE ACTINOMADURA SP. 21G792 (NRRL 30778); MÉTODO PARA PREPARAR UMA CROMOPROTEÍNA; MÉTODO PARA PREPARAR UMA CROMOPROTEÍNA MODIFICADA; MÉTODO PARA INIBIR A PROGRESSçO DE UMA DOENÇA NEOPLÁSICA EM UM MAMÍFERO; COMPOSIÇAO FARMACÊUTICA; E COMPOSTO. A presente invenção refere-se a uma cromoproteina produzida por Actinomadura sp. 21G792, bem como seqúências de aminoácidos e de ácidos nucléicos do componente de apoproteina da cromoproteina e de componentes da via biossintética para o cromáforo. A presente invenção é útil para desenvolver composições farmacêuticas e tratar doenças tais como câncer ou infecções bacterianas.
BRPI0519330-3A 2004-12-17 2005-12-16 Ácido nuclÉico isolado; vetor; cÉlula hospedeira; mÉtodo para expressar uma proteÍna; polipeptÍdeo isolado; cromoproteÍna isolada; oligonucleotÍdeo; mÉtodo para identificar um Ácido nuclÉico que codifica uma apoproteÍna de um enediina de nove membros contendo cromoproteÍna; cultura biologicamente pura de actinomadura sp. 21g792 (nrrl 30778); mÉtodo para preparar uma cromoproteÍna; mÉtodo para preparar uma cromoproteÍna modificada; mÉtodo para inibir a progressço de uma doenÇa neoplÁsica em um mamÍfero; composiÇço farmacÊutica; e composto BRPI0519330A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63739104P 2004-12-17 2004-12-17
PCT/US2005/045818 WO2006066153A2 (en) 2004-12-17 2005-12-16 Actinomadura chromoprotein, apoprotein, and gene cluster

Publications (1)

Publication Number Publication Date
BRPI0519330A2 true BRPI0519330A2 (pt) 2009-01-20

Family

ID=36588624

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0519330-3A BRPI0519330A2 (pt) 2004-12-17 2005-12-16 Ácido nuclÉico isolado; vetor; cÉlula hospedeira; mÉtodo para expressar uma proteÍna; polipeptÍdeo isolado; cromoproteÍna isolada; oligonucleotÍdeo; mÉtodo para identificar um Ácido nuclÉico que codifica uma apoproteÍna de um enediina de nove membros contendo cromoproteÍna; cultura biologicamente pura de actinomadura sp. 21g792 (nrrl 30778); mÉtodo para preparar uma cromoproteÍna; mÉtodo para preparar uma cromoproteÍna modificada; mÉtodo para inibir a progressço de uma doenÇa neoplÁsica em um mamÍfero; composiÇço farmacÊutica; e composto

Country Status (8)

Country Link
US (1) US20080274959A1 (pt)
EP (1) EP1836219A2 (pt)
JP (1) JP2008523817A (pt)
CN (1) CN101175767A (pt)
AU (1) AU2005316379A1 (pt)
BR (1) BRPI0519330A2 (pt)
CA (1) CA2587285A1 (pt)
WO (1) WO2006066153A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2029175A2 (en) * 2006-06-21 2009-03-04 Wyeth Fermentation and purification of actinomadura chromoprotein and related species
JP5387313B2 (ja) * 2009-10-08 2014-01-15 住友ベークライト株式会社 成形体の製造方法、成形体、眼鏡および防護製品
CN106916834B (zh) * 2015-12-24 2022-08-05 武汉合生科技有限公司 化合物的生物合成基因簇及其应用
CN106916835B (zh) * 2015-12-24 2022-08-12 武汉合生科技有限公司 化合物的生物合成基因簇及其应用
EP3440179B1 (en) 2016-04-06 2020-06-03 Croda International PLC Glycolipopeptide biosurfactants
US10975403B2 (en) 2017-08-09 2021-04-13 Conagen Inc. Biosynthesis of eriodictyol from engineered microbes
GB201819209D0 (en) * 2018-11-26 2019-01-09 Hypha Discovery Ltd Biocatalytic techniques
CN112359048B (zh) * 2020-08-27 2021-12-28 浙江大学 一种吕宋肽菌素c的制备方法
CN116763459A (zh) * 2023-05-11 2023-09-19 北京航空航天大学 一种金标植入体及加工方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5053394A (en) * 1988-09-21 1991-10-01 American Cyanamid Company Targeted forms of methyltrithio antitumor agents
US6583266B1 (en) * 1993-08-19 2003-06-24 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to mycobacterium tuberculosis and leprae for diagnostics and therapeutics
US6599707B1 (en) * 1998-09-11 2003-07-29 Exsar Corporation Methods for identifying hot-spot residues of binding proteins and small compounds that bind to the same
JP2002045185A (ja) * 2000-08-02 2002-02-12 Kyowa Hakko Kogyo Co Ltd Ｆ０Ｆ１−ＡＴＰａｓｅおよび該酵素をコードするＤＮＡ
US7314974B2 (en) * 2002-02-21 2008-01-01 Monsanto Technology, Llc Expression of microbial proteins in plants for production of plants with improved properties

Also Published As

Publication number Publication date
CA2587285A1 (en) 2006-06-22
JP2008523817A (ja) 2008-07-10
AU2005316379A1 (en) 2006-06-22
CN101175767A (zh) 2008-05-07
EP1836219A2 (en) 2007-09-26
WO2006066153A3 (en) 2007-12-13
US20080274959A1 (en) 2008-11-06
WO2006066153A2 (en) 2006-06-22
WO2006066153A8 (en) 2008-10-23

Similar Documents

Publication Publication Date Title
Li et al. Mesenchymal stem cell-derived exosomal microRNA-3940-5p inhibits colorectal cancer metastasis by targeting integrin α6
CN109477102A (zh) 核酸产品及其施用方法
BRPI0808940A8 (pt) anticorpo humano ou fragmento de ligação do mesmo, antígeno, polinucleotídeo, vetor, célula hospedeira, método para preparar um anticorpo ou um fragmento de ligação ou cadeia(s) de imunoglobulina do mesmo, anticorpo, cadeia de imunoglobulina ou um fragmento de ligação do mesmo, composição, usos do anticorpo ou fragmento de ligação, de um antígeno, de um polinucleotídeo, de um vetor, ou de uma célula, e de uma molécula de ligação a antígeno tumoral, método para clonagem molecular de um anticorpo, e, kit para o diagnóstico de um tumor
Shao et al. Changes of proteome components of Helicobacter pylori biofilms induced by serum starvation
BRPI0418025A (pt) molécula de ácido nucléico isolada, cassette de expressão, vetor e métodos de expressão de sequências de nucleotìdeos em plantas e células de planta
Sintsova et al. Anti-inflammatory activity of a polypeptide from the Heteractis crispa sea anemone
Lai et al. Transcriptomic analysis reveals specific osmoregulatory adaptive responses in gill mitochondria-rich cells and pavement cells of the Japanese eel
Kubota et al. Structural and functional analyses of a TIMP and MMP in the ligament of Pinctada fucata
Xu et al. High‐Level Expression of a Soluble Functional Antimicrobial Peptide, Human β‐Defensin 2, in Escherichia coli
Finoshin et al. Iron metabolic pathways in the processes of sponge plasticity
van Muilekom et al. Lost and found: The family of NF-κB inhibitors is larger than assumed in salmonid fish
ATE523591T1 (de) Verwendung eines ansatzes auf rnai-basis mit galectin-1 als ziel zur krebsbehandlung
Madusanka et al. Transcriptional modifications and the cytoprotective, DNA protective, and wound healing effects of peroxiredoxin-1 from Sebastes schlegelii
Yan et al. Synthesis of queuine by colonic gut microbiome via cross‐feeding
BRPI0406680A (pt) Métodos para selecionar um animal para ter propriedades desejadas genotìpicas ou fenotìpicas em potencial, para modular a trascrição de mrna de um gene igf2 em uma célula ou organismo provido com referido gene e para identificar um composto, composto, composição farmacêutica, e, uso de um composto
Udayantha et al. Molecular characterization, immune and xenobiotic responses of glutathione S-transferase omega 1 from the big-belly seahorse: Novel insights into antiviral defense
Zou et al. Circ004463 promotes fibroblast proliferation and collagen I synthesis by sponging miR-23b and regulating CADM3/MAP4K4 via activation of AKT/ERK pathways
Jiao et al. Comprehensive transcriptome analysis reveal key molecular events in the pearl oyster after pre-grafting conditioning
Chigwechokha et al. Nile Tilapia Neu3 sialidases: Molecular cloning, functional characterization and expression in Oreochromis niloticus
Yoshihara et al. Superficial zone chondrocytes in normal and osteoarthritic human articular cartilages synthesize novel truncated forms of inter-alpha-trypsin inhibitor heavy chains which are attached to a chondroitin sulfate proteoglycan other than bikunin
Rodrigo et al. Functional characterization of peroxiredoxin 5 from yellowtail clownfish (Amphiprion clarkii): Immunological expression assessment, antioxidant activities, heavy metal detoxification, and nitrosative stress mitigation
Schmitz et al. Hyaluronan oligosaccharide treatment of chondrocytes stimulates expression of both HAS-2 and MMP-3, but by different signaling pathways
WO2006066153A8 (en) Actinomadura chromoprotein, apoprotein, and gene cluster
Li et al. Temporal and spatial expression of fgfbp genes in zebrafish
Bui et al. Discovery of dual ROCK1/2 inhibitors from Nocardiopsis sp. under metal stress

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]